Moffitt Cancer Center Specialty License Plate Now on Sale
TAMPA, Fla. (Oct. 1, 2014) – Money from each plate sold will directly support cancer research at Moffitt
Moffitt Cancer Center Recognizes National Breast Cancer Awareness Month
TAMPA, Fla. (Sept. 30, 2014)
Moffitt Cancer Center Teams Up with Shula’s Steak House to Fight Breast Cancer
TAMPA, Fla. (Sept. 25, 2014) – Guests can order special menu items to support The Shula Fund during the month of October.
Moffitt Cancer Center and FORMA Therapeutics Establish Multiyear Epigentics Alliance
TAMPA, Fla. and WATERTOWN, Mass., (Sept. 23, 2014) – Alliance to be co-led at Moffitt by Drs. Ed Seto and Eduardo Sotomayor
Moffitt Cancer Center Study Finds Few Physicians are Recommending HPV Vaccination for Boys
TAMPA, Fla. (Sept. 17, 2014)
Moffitt Cancer Center and Total Cancer Care® Personalize Radiation Treatment
TAMPA, Fla. (Sept. 15, 2014) - Genomically-guided radiation therapy could improve patient outcomes and reduce costs.
Moffitt Cancer Center Researchers Help Lead International Efforts to Find New Genetic Links to Prostate Cancer
TAMPA, Fla. (Sept. 15, 2014) – Collaboration identifies 23 new gene variants linked to prostate cancer risk
New Moffitt Cancer Center Clinical Trial Offers Glioblastoma Patients Personalized Care Options
TAMPA, Fla. (Sept. 4, 2014) – Brain tumor vaccine will use patient’s own cells to fight cancer
Moffitt Cancer Center Plays Pivotal Role in FDA Approval of New Anti-PD-1 Inhibitor Keytruda for Metastatic Melanoma
TAMPA, Fla. (Sept. 4, 2014) – The U.S. Food and Drug Administration (FDA) announced the approval of a new cancer immunotherapy today to treat patients with metastatic melanoma, Keytruda (pembrolizumab) by Merck & Co.
Moffitt Cancer Center Presents Latinos y el cáncer Educational Symposium
TAMPA, Fla. (Sept. 2, 2014) – Free event featuring a variety of speakers will be conducted entirely in Spanish